Two independent directors at embattled Gensol Engineering resigned, the company said on Thursday, marking the third exit this ...

Reshma Kewalramani, the Indian-origin CEO of US-based Vertex Pharmaceuticals, a leading biotechnology company, has been ...

Celebrities like Tom Brady and Tiger Woods support the project. The Dallas-based biotechnology firm, founded by Ben Lamm, has emerged as a trailblazer in de-extinction science. But Lamm is clear ...

India's anti-obesity drug market has surged, growing over fourfold in five years, reaching ₹576 crore by March 2025, driven by lifestyle diseases and increased affordability. Semaglutide, particularly ...

Danish pharma giant Novo Nordisk is preparing to launch blockbuster anti-diabetes and weight-loss drug Wegovy (semaglutide) in India. To get an edge over Eli Lilly's brand Mounjaro (tirzepatide), ...

Renault Nissan Automotive India Pvt Ltd, becoming the sole owner. This move will enhance Renault's international presence, while Nissan remains committed to the Indian market with new SUVs and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

India All Stars is set to host Brazil Legends in an exhibition match at the Jawaharlal Nehru Stadium, Chennai on 30 March. The clash will see legends of yesteryear, including Ronaldinho, Rivaldo ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Thursday, April 3rd, IPO Scoop reports. The company will be issuing 2,700,000 shares at $7.50-$8.50 per share.

In a landmark initiative aimed at transforming India into a global biotechnology hub, Union Minister Dr. Jitendra Singh announced the establishment of Regional BIRAC (Biotechnology Industry Research ...